Home > Browse Reports > Medical Devices > Disposable Syringe Markets

Report Description

Disposable Syringe Markets
Publication Date: 19-JUL-07
Pages: 159
Study: TMRDSM
Format/Price: PDF document / $3,400.00
   


Description:



View Sample PDF


This TriMark Publications report examines the disposable syringe markets as well as the supplies utilized in clinics and by patients directly in their homes to diagnose and monitor disease and to administer medications. This analysis is intended to provide basic market data pertaining to the U.S. and worldwide market segments. Each market segment is analyzed to determine size, growth rates, sales projections and factors influencing growth in the U.S. and internationally. Unit and dollar volume are used to indicate market sizes. Additionally, this review examines industry challenges and potential threats to syringe and needle supplies manufacturers and makes strategic recommendations for boosting market share. The emphasis is on those companies actively developing and marketing products to hospitals, physicians and the general public for medically related uses. The disposable syringe market segments are identified as: 1) total reusable needle and syringe market; 2) total disposable needle and syringe market; 3) prefilled syringes; 4) safety syringes; 5) insulin injector pens; 6) needleless injectors; 7) vaccination injectors; 8) blood collection needles and syringes; 9) hypodermic needles and syringes market; 10) insulin needles and syringes market; 11) specialty needles and syringes market; and 12) needleless injector market.





Table of Contents:

  1. 1. Introduction 4
  2. 1.1 Statement of Report 4
  3. 1.2 About This Report 4
  4. 1.3 Scope of the Report 4
  5. 1.4 Objectives 5
  6. 1.5 Methodology 6
  7. 1.6 Executive Summary 6
  8. 2. Disposable Syringe Markets 7
  9. 2.1 Overview 7
  10. 2.2 Infection Control and Safety 9
  11. 2.3 Hospital Consolidations Pressure Companies to Reduce Prices 13
  12. 2.4 Needleless Injector Manufacturers Forge Strategic Alliances 13
  13. 2.5 Technological Advancements in Disposable Syringes 13
  14. 3. Syringe Market Segments 16
  15. 3.1 Overview 16
  16. 3.1.1 World Market 16
  17. 3.1.2 U.S. Market 18
  18. 3.2 Total Reusable Needle and Syringe Market 18
  19. 3.3 Total Disposable Needle and Syringe Market 18
  20. 3.3.1 Drivers of Safety Syringes 20
  21. 3.3.2 Restraints to Safety Syringes 20
  22. 3.4 Pre-filled Syringes 21
  23. 3.5 Insulin Injector Pens 23
  24. 3.6 Needleless Injectors 24
  25. 3.7 Vaccination Injectors 25
  26. 3.8 Needle and Syringe Market Trends 27
  27. 3.8.1 Market Segments 27
  28. 3.8.2 Customer Needs 27
  29. 3.8.3 Competitor Analysis 28
  30. 3.8.4 Target Markets for Specialty Syringes 31
  31. 3.8.5 Third Party Reimbursement 31
  32. 3.8.6 Regulation 31
  33. 3.8.7 Drug Discovery Trends 32
  34. 3.8.8 Demographic Shifts 32
  35. 3.8.9 Managed Care Initiatives 32
  36. 3.8.10 Growth in Home Healthcare 34
  37. 4. Technology Development and Sterilization Methods 36
  38. 4.1 Disposable Syringes 36
  39. 4.1.1 Autodestruct Syringes 37
  40. 4.1.2 SoloShot™ 37
  41. 4.2 Monodose Syringes 38
  42. 4.3 Pre-filled Syringes 39
  43. 4.3.1 Features of Pre-filled Membrane Syringes 40
  44. 4.3.1.1 Products in Pre-filled Syringes 42
  45. 4.3.1.2 Compatibility of Drug Components 45
  46. 4.3.1.3 Lyophilized Drugs and Powders 46
  47. 4.3.1.4 Dual-chambered Syringes 46
  48. 4.3.1.5 Pre-filled Diluent Syringes 47
  49. 4.3.1.6 Needle Safety Devices for Pre-filled Syringes 47
  50. 4.3.1.7 Sterility Maintenance 48
  51. 4.3.2 Pen Syringes 49
  52. 4.3.2.1 Technical Advances in Pens 50
  53. 4.3.2.2 Advantages of Pens 51
  54. 4.3.2.3 Pen Types and Styles 51
  55. 4.3.2.4 Pre-filled Pens 51
  56. 4.3.2.5 Reusable Pens 52
  57. 4.3.2.6 Device Preparation 52
  58. 4.3.2.7 Autopen 53
  59. 4.3.2.8 Unifine Pentips 53
  60. 4.3.3 Autoject 2 53
  61. 4.4 Insulin Syringes 53
  62. 4.5 Jet Injectors 57
  63. 4.6 Insulin Pens 58
  64. 4.7 Uniject™ Injection Device 60
  65. 4.8 Microneedle 63
  66. 4.9 Needle Free Injection 63
  67. 4.9.1 Hypospray 64
  68. 4.10 Glass Pre-fillable Syringes 64
  69. 4.11 Retractable Syringe 64
  70. 4.12 Ultrasafe Passive Delivery Systems 65
  71. 4.13 Ultrasmall Syringes and Microsyringes 66
  72. 4.14 Tip Lok® Syringes 66
  73. 4.15 Product Profiles 66
  74. 4.15.1 Gettig Guard™ 66
  75. 4.15.2 Inviro SNAP! ® 66
  76. 4.15.3 Maxxon Safety Syringe 67
  77. 4.15.4 Monoject Magellan™ 67
  78. 4.15.5 Needle-Pro 67
  79. 4.15.6 Point Lok® 67
  80. 4.15.7 SafetyGlide™ 68
  81. 4.16 SC Injection Technology 68
  82. 5. Business Trends 70
  83. 5.1 Market Drivers 70
  84. 5.2 Market Prospects 73
  85. 5.3 Marketing and Distribution 73
  86. 5.4 Competitive Landscape 74
  87. 5.5 Business Developments 75
  88. 5.6 Acquisitions and Partnerships 76
  89. 5.7 Key Players 76
  90. 5.7.1 Kendall 76
  91. 5.7.2 Becton Dickinson 77
  92. 5.7.3 C.R. Bard 77
  93. 5.7.4 International Medication Systems 78
  94. 5.7.5 Terumo Medical Corporation 79
  95. 6. Future Technologies 80
  96. 6.1 Thermostable Vaccines and Vaccine Vial Monitors 80
  97. 6.2 Sugar Glass 80
  98. 6.3 Issues in Technology Transfer for AD Syringes 82
  99. 7. Regulatory Measures 84
  100. 7.1 Safety Syringes in Europe 84
  101. 7.2 Safety Syringe Regulations and Recommendations 85
  102. 7.3 Reimbursement Outlook for Injectables 86
  103. 8. Corporate Profiles 87
  104. 9. Corporate Directory 126
  105. Appendix 1: FDA Approved Syringe Manufacturers 136
  106. Appendix 2: NAPPSI Primary and Secondary Prevention: Needlestick Safety Device List 143
  107. Appendix 3: Ambulatory Care Services OSHA/Safety Device Listing 147
  108. Appendix 4: Frequently Asked Questions for the Needlestick and Safety Prevention Act 156
  109. INDEX OF FIGURES
  110. Figure 3.1: U.S. Safety Needle and Syringe Market 19
  111. Figure 6.1: Strategy of the "Sugar Project" 82
  112. INDEX OF TABLES
  113. Table 2.1: Global Market for Needles and Syringes, 2001-2010 8
  114. Table 3.1: Global Market for Injection Devices by Category 16
  115. Table 3.2: Worldwide Dollar Market for Needles and Syringes, 1996-2010 17
  116. Table 3.3: Worldwide Unit Market for Needles and Syringes, 1996-2010 17
  117. Table 3.4: U.S. Dollar Market for Needles and Syringes, 1999-2010 18
  118. Table 3.5: Worldwide Disposable Needle and Syringe Market, 1998 2006 19
  119. Table 3.6: Worldwide Market for Disposable Needles and Syringes by Region 19
  120. Table 3.7: Worldwide Safety Syringe Unit Sales, 1998 2006 20
  121. Table 3.8: Worldwide Safety Syringe Dollar Volume, 1998 2006 21
  122. Table 3.9: Share of Worldwide Safety Syringes Market by Competitor 21
  123. Table 3.10: Share of Worldwide Market for Safety Syringes by Region 21
  124. Table 3.11: Worldwide Pre-filled Syringe Unit Sales, 1998 2010 22
  125. Table 3.12: Worldwide Pre-filled Syringe Dollar Volume, 1998 2006 22
  126. Table 3.13: Share of Worldwide Pre-filled Syringe Market by Competitor 22
  127. Table 3.14: Share of Worldwide Market for Pre-filled Syringes by Region 22
  128. Table 3.15: Worldwide Insulin Injector Pen Dollar Volume, 1998 2006 23
  129. Table 3.16: Worldwide Market for Needle Free Injectable Drug Delivery Systems, 1996-2005 24
  130. Table 3.17: Worldwide Needleless Injector Dollar Volume, 1998 2006 24
  131. Table 3.18: Worldwide Vaccination Injector Unit Sales, 1998 2006 25
  132. Table 3.19: Share of Worldwide Market for Vaccination Injectors by Region 25
  133. Table 3.20: Worldwide Vaccination Injector Dollar Volume, 1998 2006 25
  134. Table 3.21: Share of Worldwide Vaccination Injector Market by Competitor 25
  135. Table 3.22: Summary of Strengths and Weaknesses of Available Syringes 31
  136. Table 3.23: Annual Change Per Capita in Healthcare Spending and Gross Domestic Product, 1994 2004 35
  137. Table 4.1: Injection Data Using Soloshot and Disposable Syringes 37
  138. Table 4.2: Summary Data for Doses by Soloshot and Disposable Syringes 38
  139. Table 4.3: Wastage Analysis (Per Vial Used) 38
  140. Table 4.4: Important Injectable Drug Therapies Using Pre-filled Devices 39
  141. Table 4.5: Region-wise Market of Pre-filled Syringes 43
  142. Table 4.6: Worldwide Pre-filled Syringe Unit Sales, 1998 2006 44
  143. Table 4.7: Worldwide Pre-filled Syringe Dollar Volume, 1998 2004 44
  144. Table 4.8: Insulin Delivery Systems Percent Retail Market Share 54
  145. Table 4.9: Insulin Delivery Systems Percent Retail Market Share by Company 54
  146. Table 4.10: Commonly-Available Insulin Syringes 55
  147. Table 4.11: Features of Available Insulin Pumps 56
  148. Table 4.12: Features of Available Jet Injectors 57
  149. Table 4.13: Currently Available Insulin Delivery Pens 59
  150. Table 4.14: Summary of Clinical and Field Experience with the Uniject Device 61

Registration
Browse Reports
Search TriMark
Reading Room
My Account
View Cart
Home  |  Reports  |  Database Tables  |  Conferences  |  Contact Us  
     © 2008 TriMark Publications, LLC. All rights reserved.